Call 0808 800 0035

Free osteoporosis helpline


MBE for world-leading rheumatologist

Media releases | Head office

30 Dec 2020

One of the UK’s top bone health specialists has been recognised for his commitment to osteoporosis and his work with the ROS in the Queen’s New Year’s Honours list 2021.

Professor David Reid, who is Emeritus Professor of Rheumatology at the University of Aberdeen and previously Head of the School of Medicine & Dentistry at the University, has been awarded the Member of the Order of the British Empire (MBE) from the Queen. The honour is in recognition of his long-term support for our charity in which he has held numerous roles, including as a former Chair of the Board of the Trustees and most recently Senior Medical Advisor, as well as being a fundraising ambassador for the ROS Osteoporosis and Bone Research Academy.

Our CEO Craig Jones said: “David has been - and continues to be - a tireless supporter of our charity and has made a substantial contribution to advances in the treatment and care of people living with osteoporosis. We’re proud and delighted that his efforts have been recognised with an MBE in the Queen’s New Year’s Honours list.”

Professor Reid trained as a rheumatologist at the University of Aberdeen before moving to the University of Edinburgh, where he began studying the effect of steroids on bone health. He went on to work on pioneering techniques for analysing bone density, before becoming involved with the ROS.

David has recently returned to clinical practice where osteoporosis remains his passion – treating people living with osteoporosis and at risk of broken bones. As a member of our Osteoporosis and Bone Research Academy’s Advisory Committee, David also continues to work with our team to raise the funds needed to accelerate pioneering research, as outlined in the recently launched Research Roadmap.

Professor Reid said: “I am very happy to receive this MBE - it really is an honour. I have greatly enjoyed working with the Royal Osteoporosis Society, which has made such a significant difference in the field of osteoporosis research, care, and treatment. This really is a passionate and committed team, and I look forward to working with everyone to deliver on the Research Roadmap towards a cure for osteoporosis.”